Ji Yeon Hong
Research Subjects
Ji Yeon Hong has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Hong Ji
University of Texas MD Anderson Cancer Center
2 shared publications- Pierre D. McCrea
Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, United States
2 shared publications - Seung Min Bae
Department of Psychiatry, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
2 shared publications - Alexandria T. M. Blackburn Bs
Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center, Houston TX, 77030, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston TX, 77030, USA
1 shared publication Dongmin Gu
Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, TX 77030, USA
1 shared publicationHee Jin Nam
Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
1 shared publication
Latest Publications
- Open Access
Sprr1 and miR-130b contribute to the senescence-like phenotype in aging
Aging is an inevitable process with senescence being one of its hallmarks. Recent advances have indicated that the elimination of senescent cells can reduce the signs of aging and increase healthy life span. Here, we identify a negative modulator of aging, Sprr1a, and in turn a negative modulator of Sprr1a, miR-130b. We show that reductions in Sprr1a levels, including via miR-130b expression, promotes cell senescence-like phenotype. We find that mediators of senescence, such as inflammatory cytokines and cell cycle regulators, are modulated by the miR-130b and Sprr1a-related pathway. For example, the levels of p16, p53 and p21 become decreased or increased upon the respective expression of Sprr1a versus miR-130b. Further, as shown in relation to p16 levels and β-galactosidase levels, cells expressing Sprr1a exhibit significant protection from senescence-inducing factors such as radiation or Doxorubicin, suggesting that Sprr1a might contribute to protection against age-related pathologies. Taken together, we introduce two modulators of properties associated with senescence-like phenotype.
Open AccessSprr1 and miR-130b contribute to the senescence-like phenotype in aging
Aging is an inevitable process with senescence being one of its hallmarks. Recent advances have indicated that the elimination of senescent cells can reduce the signs of aging and increase healthy life span. Here, we identify a negative modulator of aging, Sprr1a, and in turn a negative modulator of Sprr1a, miR-130b. We show that reductions in Sprr1a levels, including via miR-130b expression, promotes cell senescence-like phenotype. We find that mediators of senescence, such as inflammatory cytokines and cell cycle regulators, are modulated by the miR-130b and Sprr1a-related pathway. For example, the levels of p16, p53 and p21 become decreased or increased upon the respective expression of Sprr1a versus miR-130b. Further, as shown in relation to p16 levels and β-galactosidase levels, cells expressing Sprr1a exhibit significant protection from senescence-inducing factors such as radiation or Doxorubicin, suggesting that Sprr1a might contribute to protection against age-related pathologies. Taken together, we introduce two modulators of properties associated with senescence-like phenotype.
- 28 May 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 563, 31-39
A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals
- 28 May 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 563, 31-39
A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals
- Open Access
- 31 May 2018
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 16 (2) , 129-135
The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder
Seung Min Bae, Ji Yeon Hong. Clin Psychopharmacol Neurosci 2018;16:129-35. https://doi.org/10.9758/cpn.2018.16.2.129
- 31 May 2018
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 16 (2) , 129-135
Open AccessThe Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder
Seung Min Bae, Ji Yeon Hong. Clin Psychopharmacol Neurosci 2018;16:129-35. https://doi.org/10.9758/cpn.2018.16.2.129
- Open Access
- 15 June 2012
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 125 (12) , 3012
Down’s-syndrome-related kinase Dyrk1A modulates the p120-catenin–Kaiso trajectory of the Wnt signaling pathway
- 15 June 2012
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 125 (12) , 3012
Open AccessDown’s-syndrome-related kinase Dyrk1A modulates the p120-catenin–Kaiso trajectory of the Wnt signaling pathway